In this article, HCmed Innovations discusses the role of connectivity in improving adherence to medication and introduces the company’s mesh nebuliser smart cap, Pulmogine+.
A non-commercial modified Deepro mesh nebulizer with newly developed breath-actuated function was used to nebulize iloprost and demonstrate its in-vitro delivery effectiveness, which adds an alternative for delivering this formulation.
HCmed Innovations presents the benefits of smart breath-actuated nebulisers and looks at the latest technology contributing to the evolution of nebulisers.
Originally intended dual and triple-combination formulations for jet nebulizers could be successfully delivered with three mesh nebulizer among which Pulmogine presented better performance.
Mesh nebulisers in conjunction with innovative treatments are creating a new era of drug-device combination products that aim to target all types of respiratory diseases
Deepro was found not to exhibit substantial mesh clogging during two challenge tests, considering the expected effects of clogging. The performance of the device was described as stable even when it was not washed for up to 5 days.
